ALVO's logo.
Ticker Symbol: ALVO

Alvotech

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001898416

Company Profile

alvotech was founded in 2013, with the clear mission to become a global leader in biogenerics, defined as differentiated, high-quality, cost-controlled biosimilars. we have pursued this goal by creating a fully-integrated specialty company in control of every value adding development step from cell line development to commercial manufacturing of the product. our in-house development and manufacturing platform located at four sites across europe drives timely development of a strong and differentiated portfolio, while our state-of-the-art flexible manufacturing facility, located in reykjavik iceland, ensures high quality and cost-effective production. we are passionate about what we have created and our stated purpose of transforming access to life-altering therapies for patients across the globe. we believe in focus and specialization and each of our 250 professionals share our passion and pride to be part of this mission. we are dedicated to making people's lives better by improving a

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $8.68
Change: -$0.17 ( -1.92%)
Days Range: $8.57 - $9.27
Beta: 0.17
52wk. High: $14.60
52wk. Low: $5.52
Ytd. Change -15.12%
50 Day Moving Average: $9.16
200 Day Moving Average: $9.24
Shares Outstanding: 265529722

Valuation

Market Cap: 230.5B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A